Cancer-Specific Splicing Changes and the Potential for Splicing-Derived Neoantigens
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
In this issue of Cancer Cell, Kahles et al. perform a comprehensive analysis of RNA splicing across cancer types and identify novel correlations between genetic alterations and splicing in cancer. In addition, they identify that tumor-specific splicing has the potential to generate a large new class of tumor-specific neoantigens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Noisy Splicing Drives mRNA Isoform Diversity in Human Cells
Pickrell, J. K., Pai, A. A., Gilad, Y., & Pritchard, J. K. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001236 · Cited by 311 · cited 1×
“often involves low-abundance isoforms (Pickrell et al., 2010), and the sensitivity of proteogenomic detection of neomor-”
Wang, X., Codreanu, S. G., Wen, B., Li, K., Chambers, M. C., Liebler, D. C., & Zhang, B. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000155 · Cited by 97 · cited 1×
“Moreover, it has also been noted that the enzymes most commonly used to generate peptides from full-length proteins for mass spectrometry have a tendency to cleave proteins at EEJs, thereby obscuring detection of neopeptides translated from neojunctions (Wang et al., 2018).”
Cited by
Neoantigens: promising targets for cancer therapy
Xie, N., Shen, G., Gao, W., Huang, Z., Huang, C., & Fu, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01270-x · Cited by 1,020
RNA splicing dysregulation and the hallmarks of cancer
Bradley, R. K., & Anczuków, O. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00541-7 · Cited by 579
Alternative splicing and related RNA binding proteins in human health and disease
Tao, Y., Zhang, Q., Wang, H., Yang, X., & Mu, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01734-2 · Cited by 320
Yao, T., Zhang, Z., Li, Q., Huang, R., Hong, Y., Li, C., Zhang, F., Huang, Y., Fang, Y., Cao, Q., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0083 · Cited by 22
Metadata
- Authors
- Hoyos, L. E., & Abdel-Wahab, O.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 34
- Issue
- 2
- Pages
- 181-183
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2885985208
- Cited by
- 58
- References
- 2
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer-Specific Splicing Changes and the Potential for Splicing-Derived Neoantigens. https://app.cochat.ai/papers/10.1016/j.ccell.2018.07.008
- The paper
- Hoyos, L. E., & Abdel-Wahab, O. (2018). Cancer-Specific Splicing Changes and the Potential for Splicing-Derived Neoantigens. Cancer Cell. https://doi.org/10.1016/j.ccell.2018.07.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.